Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration

Monogram Technologies Inc. has announced a strategic collaboration with Shalby Limited to conduct a multicenter clinical trial. This follows the successful 510(k) submission and FDA Administrative Review for the mBȏs TKA System. Shalby, a global leader in orthopedic surgeries, will enroll patients at various sites in India to evaluate the system's safety and effectiveness.

Shalby, which performs over 14,000 knee replacement surgeries annually, represents around 15% of the arthroplasty market in India. Under this collaboration, Shalby will use the Consensus CKS implant, equivalent to Monogram's mPress implants for regulatory purposes. The trial includes the potential post-trial transfer of a robot to Shalby under specific conditions.

Monogram's CEO, Ben Sexson, emphasized the significant market potential in India for robotics, while Dr. Vikram Shah, Chairman of Shalby, expressed enthusiasm about the partnership and the transformative potential of Monogram's technology.